Workflow
US FDA approves Otsuka's kidney disease drug
Symbotic Symbotic (US:SYM) Reutersยท2025-11-25 20:12

Core Insights - The U.S. Food and Drug Administration has approved Otsuka's injectable drug for treating a potentially life-threatening kidney disease [1] Company Summary - Otsuka has received FDA approval for its injectable drug, indicating a significant advancement in its product offerings and potential market impact [1]